Regulation of ROS production and vascular function by carbon monoxide

Oxid Med Cell Longev. 2012:2012:794237. doi: 10.1155/2012/794237. Epub 2012 Aug 9.

Abstract

Carbon monoxide (CO) is a gaseous molecule produced from heme by heme oxygenase (HO). CO interacts with reduced iron of heme-containing proteins, leading to its involvement in various cellular events via its production of mitochondrial reactive oxygen species (ROS). CO-mediated ROS production initiates intracellular signal events, which regulate the expression of adaptive genes implicated in oxidative stress and functions as signaling molecule for promoting vascular functions, including angiogenesis and mitochondrial biogenesis. Therefore, CO generated either by exogenous delivery or by HO activity can be fundamentally involved in regulating mitochondria-mediated redox cascades for adaptive gene expression and improving blood circulation (i.e., O(2) delivery) via neovascularization, leading to the regulation of mitochondrial energy metabolism. This paper will highlight the biological effects of CO on ROS generation and cellular redox changes involved in mitochondrial metabolism and angiogenesis. Moreover, cellular mechanisms by which CO is exploited for disease prevention and therapeutic applications will also be discussed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Blood Vessels / drug effects*
  • Blood Vessels / physiology*
  • Carbon Monoxide / pharmacology*
  • Carbon Monoxide / therapeutic use
  • Humans
  • Neovascularization, Physiologic / drug effects
  • Oxidation-Reduction / drug effects
  • Reactive Oxygen Species / metabolism*
  • Vascular Diseases / drug therapy
  • Vascular Diseases / pathology
  • Vascular Diseases / physiopathology

Substances

  • Reactive Oxygen Species
  • Carbon Monoxide